Tag Archives: European Union

Europe: Countdown Time for the Innovative Medicines Initiative?

Momentum is gathering in Brussels for real battles over carving up the 1 trillion dollars that the European Union has now agreed to spend between the end of this year and the end of the decade. The constituencies jostling for funding include farmers and foreign aid workers, teachers and train operators, and legislators and local [...]
Posted in Global, Guest Blog | Also tagged , , , , | Leave a comment

Saving Greece's Healthcare System: A Harbinger for Europe?

A just-published report from the European taskforce trying to help Greece crawl out of its crisis makes clear just how significant a role health reform is supposed to play in restoring health to the economy. It is, in a very acute form, a harbinger of what is around the corner for the other countries of [...]
Posted in Europe, Global, Guest Blog, healthcare | Also tagged , , , , , | Leave a comment

Thinking of Phase IV Trials? Europe Might See Things Differently…

By Peter O’ Donnell. With the shadow cast by Mediator across Europe now receding to a focus on the French law courts, the European Union (EU) said in late November that its pharmacovigilance arrangements offer “one of the most advanced and comprehensive systems in the world”. Certainly the EU’s legislative framework has been significantly boosted over [...]
Posted in Europe, Global, Guest Blog, R&D | Also tagged , , , | Leave a comment

EU Pins Hopes on HTA Network for Consensus on Value

The European Union’s proposed health technology assessment network to encourage “cooperation and exchange of scientific information among member states” is a significant step, says Reflector. But, as far as standardizing an approach to value is concerned, will it be a damp squib?
Posted in Europe, Global, Guest Blog, pricing | Also tagged , , , , , | Leave a comment

Patients Wade into the European Pricing Debate

Patient groups are a growing force, not just in the debate around tactical areas of medical specialities, but also on the vital question of pricing and reimbursement rules. But will their voices be heard? Reflector reports. An important third party is struggling to make its voice heard in European pharma discussions. Drug pricing is not just [...]
Posted in Europe, Global, Guest Blog, Regulatory, healthcare, pricing | Also tagged , , , , | Leave a comment